Sex Hormone Treatment for Female Children and Young Adults with Disorders Affecting Hypothalamic, Pituitary, and Ovarian Function
Hormone Research in Paediatrics · 2024
DOI: 10.1159/000539697 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Hormone Research in Paediatrics, 2024. Verfasst von Christoph Saner und 7 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Endocrinology, Diabetology, and Metabolism, Department of Pediatrics, University Children's Hospital Bern, Inselspital Bern, Bern, Switzerl…. Hauptthemen laut MEDLINE: Gonadal Steroid Hormones, Hormone Replacement Therapy, Polycystic Ovary Syndrome, Hypothalamo-Hypophyseal System. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background: Normal hypothalamic-pituitary-ovarian (HPO) endocrine function is essential for female pubertal and psychosocial development and for ongoing adult physical, sexual, and psychosocial health. Girls with hypogonadism, any endocrine disorder causing abnormal uterine bleeding (AUB) or with contraception needs may require sex hormone treatment. Challenges include evolving needs of a young girl through the course of sexual maturation, potential health risks related to the use of sex hormones for pubertal induction, hormone replacement therapy (HRT), menstrual management, and/or contraception. Summary: To ensure optimal sex hormone treatment, both a comprehensive understanding of the underlying disorder affecting HPO endocrine function and a professional communication with the patient and physicians involved are warranted. In this narrative mini-review, we discuss pubertal induction and HRT for girls with hypogonadism and the management of AUB and contraception for young women up to age 30 years. Additionally, we provide advice on management of AUB and contraception in young women with common conditions including polycystic ovary syndrome, congenital adrenal hyperplasia and others. A PubMed-literature search including articles published over the last 20 years, together with clinical experience of the authors was integrated to provide treatment recommendations. Key Message: Sex hormone treatment, where needed, requires comprehensive understanding of a range of available options. When tailored to individual needs, with flexibility to accommodate changing circumstance in young women it is safe, well tolerated and provides both physical and psychosocial health.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pediatric Endocrinology, Diabetology, and Metabolism, Department of Pediatrics, University Children's Hospital Bern, Inselspital Bern, Bern, Switzerland.
- Department of Obstetrics and Gynecology, University Hospital of Bern and University of Bern, Bern, Switzerland.
- Department of Biomedical Research, University of Bern, Bern, Switzerland.
- Department of Endocrinology, Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, Victoria, Australia.
Zitieren
APA
Saner, C., Ochsner, H., Saner, F. A. M., Flück, C. E., Atlas, G., Wueest, A., Zacharin, M., & Saner, C. (2024). Sex Hormone Treatment for Female Children and Young Adults with Disorders Affecting Hypothalamic, Pituitary, and Ovarian Function. Hormone Research in Paediatrics. https://doi.org/10.1159/000539697
Vancouver
Saner C, Ochsner H, Saner FAM, Flück CE, Atlas G, Wueest A, et al. Sex Hormone Treatment for Female Children and Young Adults with Disorders Affecting Hypothalamic, Pituitary, and Ovarian Function. Hormone Research in Paediatrics. 2024. doi:10.1159/000539697
BibTeX
@article{Saner2024,
author = {Saner, Christoph and Ochsner, Hannah and Saner, Flurina Annacarina Maria and Flück, Christa E and Atlas, Gabby and Wueest, Anja and Zacharin, Margaret and Saner, Christoph},
title = {Sex Hormone Treatment for Female Children and Young Adults with Disorders Affecting Hypothalamic, Pituitary, and Ovarian Function},
journal = {Hormone Research in Paediatrics},
year = {2024},
doi = {10.1159/000539697}
}
EUVIMED